But myeloma doesn't disappear when March ends, and neither should the conversation.
Myeloma, also called multiple myeloma, is a cancer of plasma cells, a type of white blood cell found in the bone marrow. When abnormal plasma cells multiply, they can interfere with normal blood-cell production and cause problems throughout the body, including bone damage, anemia, kidney problems, weakened immunity, and recurrent infections.
One of the challenges with myeloma is that its early signs can be easy to dismiss or mistaken for other conditions. Bone or back pain, persistent fatigue, frequent infections, unexplained anemia, kidney problems, high calcium levels, or unexplained weight loss can all occur with myeloma. Some people have few or no noticeable symptoms when abnormal bloodwork first leads to further testing.
That is one reason awareness matters.
For many patients, the first time they hear the words multiple myeloma is when they are being told they have it. Suddenly, they and their families are trying to understand plasma cells, M-proteins, light chains, bone marrow biopsies, treatment options, and a cancer they may not have known existed.
Treatment Has Changed—But We Still Need a Cure
The myeloma treatment landscape has changed dramatically. Today's patients may have access to combinations of targeted therapies, immunomodulatory drugs, proteasome inhibitors, monoclonal antibodies, stem cell transplantation, CAR T-cell therapy, bispecific antibodies, and other emerging treatments.
These advances have allowed many people to live longer and better lives with myeloma than was possible in the past.
But myeloma is still generally considered treatable rather than curable. Some patients achieve deep, long-lasting remissions, while others face repeated relapses and multiple lines of treatment.
That is why continued research matters.
We need better ways to detect myeloma earlier, treatments that are more effective with fewer long-term side effects, greater access to promising therapies, and ultimately a cure.
Awareness Is About More Than Knowing the Name
Awareness also means understanding what patients and their families live with after diagnosis.
Myeloma can bring physical challenges from both the disease and its treatments, but the impact doesn't stop there. There can be emotional strain, financial pressure, uncertainty about the future, changes in relationships and careers, and the exhaustion of living from one laboratory result or appointment to the next.
Caregivers carry their own burdens, too.
Support organizations, patient advocates, coaches, researchers, healthcare professionals, families, and other patients can all help make that journey a little less isolating.
And sometimes awareness begins with something as simple as sharing accurate information.
March Ends. Myeloma Doesn't.
Myeloma Awareness Month gives us an opportunity every March to make more people aware of this disease. But for those living with myeloma, there is no awareness-month calendar.
They live with it in April.
And July.
And November.
They live with it while waiting for bloodwork, celebrating remission, starting another treatment, worrying about a rising number, rebuilding strength after a transplant, or simply trying to enjoy an ordinary Tuesday without thinking about cancer.
So when March ends, let's keep talking.
Keep educating.
Keep supporting patients and caregivers.
Keep challenging misinformation.
Keep advocating for research and better access to treatment.
And keep reminding the world that behind every myeloma statistic is a person—and behind that person is often an entire family whose life changed with one diagnosis.
Awareness shouldn't last a month.
Myeloma is for life, and until we have a cure, awareness should be too.